Maravai LifeSciences Quarterly Balance Sheet
NASDAQ: MRVIHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Maravai LifeSciences financial position
As of Jun 30, 2026, Maravai LifeSciences reported total assets of $603.7 million, down 32.7% from a year earlier against total liabilities of $248.2 million. Shareholders' equity stood at $204.6 million, or 33.9% of assets. The company held $70.1 million in cash and equivalents against $147.1 million of debt, a net debt position of $77.0 million.
The current ratio (current assets divided by current liabilities) was 4.05, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.72.
Summary generated from market data by MetaCap's automated system. Methodology
Maravai LifeSciences balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 70.09M | 165.92M | 216.89M | 243.57M | 269.91M | 285.05M | 322.40M | 578.16M | 573.17M | 561.69M | 574.96M | 579.61M |
| Receivables | 31.14M | 33.41M | 25.50M | 22.54M | 27.88M | 28.49M | 38.52M | 28.79M | 34.74M | 36.69M | 54.60M | 45.67M |
| Inventory | 41.23M | 40.46M | 40.49M | 45.33M | 46.67M | 49.77M | 50.08M | 50.53M | 49.34M | 49.85M | 51.40M | 49.14M |
| Total Current Assets | 155.66M | 251.74M | 296.25M | 325.87M | 359.76M | 376.28M | 429.15M | 679.14M | 681.50M | 667.88M | 699.91M | 700.87M |
| Property, Plant & Equipment | 142.41M | 146.93M | 151.48M | 158.62M | 162.73M | 166.43M | 164.47M | 164.56M | 165.50M | 161.63M | 162.90M | 153.56M |
| Goodwill | 129.43M | 129.43M | 129.43M | 129.43M | 129.43M | 159.88M | 159.88M | 171.79M | 326.03M | 326.03M | 326.03M | 326.03M |
| Intangible Assets | 138.38M | 144.89M | 151.54M | 185.88M | 193.07M | 199.58M | 194.96M | 201.86M | 207.25M | 214.12M | 220.99M | 227.86M |
| Total Assets | 603.75M | 713.22M | 770.58M | 849.19M | 896.97M | 959.75M | 1.01B | 1.28B | 1.44B | 1.44B | 1.49B | 2.27B |
| Accounts Payable | 7.13M | 8.54M | 2.91M | 8.00M | 11.53M | 9.53M | 11.96M | — | — | — | — | — |
| Short-Term Debt | 1.13M | 5.44M | 5.44M | 5.44M | 5.44M | 5.44M | 5.44M | 5.44M | 5.44M | 5.44M | 5.44M | 5.44M |
| Total Current Liabilities | 38.42M | 42.62M | 44.92M | 61.57M | 69.68M | 63.16M | 56.97M | 63.71M | 68.62M | 59.02M | 87.47M | 78.25M |
| Long-Term Debt | 145.98M | 235.57M | 286.33M | 287.38M | 288.44M | 289.50M | 290.49M | 516.28M | 517.08M | 517.89M | 518.71M | 519.52M |
| Total Liabilities | 248.16M | 344.13M | 397.87M | 417.33M | 428.98M | 429.48M | 431.04M | 665.56M | 671.26M | 667.25M | 697.57M | 1.38B |
| Shareholders' Equity | 204.62M | 211.56M | 212.38M | 245.44M | 265.86M | 300.61M | 325.29M | 344.90M | 434.73M | 410.66M | 416.75M | 519.29M |
| Retained Earnings | -6.03M | 6.38M | 10.12M | 45.80M | 71.36M | 110.95M | 140.89M | 166.80M | 263.87M | 273.66M | 285.74M | 391.70M |
| Total Debt | 147.10M | 241.01M | 291.77M | 292.82M | 293.88M | 294.94M | 295.93M | 521.72M | 522.52M | 523.33M | 524.15M | 524.96M |
| Net Cash (Debt) | -77.01M | -75.09M | -74.88M | -49.25M | -23.97M | -9.89M | 26.47M | 56.43M | 50.65M | 38.36M | 50.81M | 54.65M |
This table shows 12 quarterly periods of Maravai LifeSciences's balance sheet, from Q2 2026 back to Q3 2023, across 17 line items including cash & equivalents, receivables, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow MRVI's reporting calendar. What is a balance sheet?